Atrophic vaginitis is a disorder in which the vaginal walls become thin, dry, and irritated as estrogen levels fall, which is frequently caused by menopause or certain medical therapies. Atrophic vaginitis is typically treated with topical or systemic estrogen therapy, which helps to restore vaginal moisture and alleviate symptoms such as vaginal dryness, itching, and pain during sex.
The global Atrophic Vaginitis Market size was valued at USD 612.4 million in 2022 and is expected to grow at a CAGR of 7.5% over the forecast period 2023-2030.
Leading Companies in the Atrophic Vaginitis Treatment Industry:
1. Pfizer Inc.
Cochlear Limited founded in 1983 and its headquarters Sydney, Australia. The company operates in 100 countries.
2. TherapeuticsMD Inc.
Boston Scientific Corporationfounded in 1907, and its Headquarters located in Boca Raton, Florida, United States. The company operates in 60 nations. acquisition and forthcoming launch of ANNOVERA™, we are demonstrating our intent to provide effective and innovative products for women
3. Allergan plc (AbbVie Inc.)
Philips Healthcare was launch in 1949 and it’s headquarter located Dublin, Ireland.it operate over 100 country. Allergan plc (NYSE: AGN) ("Allergan") announced that AbbVie has now completed the acquisition of Allergan pursuant
4. Duchesnay USA
Duchesnay USA was launch in 2013 and it’s headquarter, located in USA..it operate over 50 country In world.
5. Novo Nordisk A/S
Novo Nordisk A/Swas founded 1923 with its headquarters in Bagsværd, Denmark. With businesses in over 160 countries.In 2022 Novo Nordisk and Flagship Pioneering announce a strategic collaboration to create a portfolio of transformational medicines
6. Merck & Co., Inc.
Merck & Co., Inc.was launch in 1841. And its headquarter - Rahway, New Jersey, United States. It operate over 193 country.
7. Endoceutics Inc
Endoceutics Inc founded in 2006 and it’s headquarter located Canada .It operate over 130 country. EndoCeutics Inc. Development of prasterone to treat vaginal atrophy and female sexual dysfunction. Evotec AG.
*Definition- Atrophic vaginitis is a condition in which the vaginal walls become thin, dry, and inflamed due to a decrease in estrogen levels, often caused by menopause or certain medical treatments.
